Company intelligence / Profile preview

Shanghai Jinwei Biotechnology Co., Ltd.

Shanghai（上海）, Shanghai Shi（上海市）, 中国（China）jinweibio.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Jinwei has demonstrated early clinical activity with lentiviral vector-based therapies in infectious disease (HIV) trials. Its technologies are advancing toward broader applications in cancer immunotherapy and other serious diseases. The company’s lentiviral vectors have received regulatory approval for further clinical testing in HPV indications

Therapeutic areas: OncologyInfectious Diseases
Modalities: Lentiviral vectorsgene therapy platformscryptic peptide technology
Industry: Biotech

Drug pipeline

1 asset

lentiviral vector therapeutic HBV vaccine

Preclinical

Partnerships

Pasteur Institute (France): Exclusive licenses on lentiviral IP/patentsTheravectys S.A.S.: Licensing partner on lentivirus technologyHuashan Hospital partnership; participant in national science projects

Beyond the preview

Go deeper on Shanghai Jinwei Biotechnology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Jinwei Biotechnology Co., Ltd..

Explore the full profile